Illumina Says New HumanOmni Chip 'Important Flagship' for Next Round of GWAS

The array is intended to replace the firm's existing 1.2-million feature Human1M-Duo BeadChip as its main offering for researchers conducting genome-wide association studies, CEO Jay Flatley said this week.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.